Cargando…
From Variation of Influenza Viral Proteins to Vaccine Development
Recurrent influenza epidemics and occasional pandemics are one of the most important global public health concerns and are major causes of human morbidity and mortality. Influenza viruses can evolve through antigen drift and shift to overcome the barriers of human immunity, leading to host adaption...
Autores principales: | Zhu, Wandi, Wang, Chao, Wang, Bao-Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536042/ https://www.ncbi.nlm.nih.gov/pubmed/28718801 http://dx.doi.org/10.3390/ijms18071554 |
Ejemplares similares
-
Promising Adjuvants and Platforms for Influenza Vaccine Development
por: Zhu, Wandi, et al.
Publicado: (2021) -
Influenza Vaccines toward Universality through Nanoplatforms and Given by Microneedle Patches
por: Tang, Sijia, et al.
Publicado: (2020) -
Enhanced Immune Responses Conferring Cross-Protection by Skin Vaccination With a Tri-Component Influenza Vaccine Using a Microneedle Patch
por: Zhu, Wandi, et al.
Publicado: (2018) -
Dual-linker gold nanoparticles as adjuvanting carriers for multivalent display of recombinant influenza hemagglutinin trimers and flagellin improve the immunological responses in vivo and in vitro
por: Wang, Chao, et al.
Publicado: (2017) -
Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins
por: Jazayeri, Seyed Davoud, et al.
Publicado: (2019)